ADVFN - ニュース

S&P 500

5,222.68

0.16%

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/11	05 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:CC	Chemours Company
2024/05/11	05 : 03	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:SCSC	ScanSource Inc
2024/05/11	05 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TSCO	Tractor Supply Company
2024/05/11	05 : 03	PR Newswire (Canada)	La Sun Life annonce l'élection des administrateurs	TSX:SLF	Sun Life Financial Inc
2024/05/11	05 : 03	PR Newswire (Canada)	La Sun Life annonce l'élection des administrateurs	NYSE:SLF	Sun Life Financial Inc
2024/05/11	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TTMI	TTM Technologies Inc
2024/05/11	05 : 02	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:AMJB	Alerian Mlp Index ETNs due January 28 2044
2024/05/11	05 : 02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:COEPW	Coeptis Therapeutics Holdings Inc
2024/05/11	05 : 02	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	NASDAQ:ANTE	AirNet Technology Inc
2024/05/11	05 : 02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CHUY	Chuy s Holdings Inc
2024/05/11	05 : 02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:EUBG	Entrepreneur Universe Bright Group (QB)
2024/05/11	05 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:WBS	Webster Financial Corporation
2024/05/11	05 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTC	PTC Inc
2024/05/11	05 : 02	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:AMGN	Amgen Inc
2024/05/11	05 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:GHLD	Guild Holdings Company
2024/05/11	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:AUB	Atlantic Union Bankshares Corporation
2024/05/11	05 : 02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TLS	Telos Corporation
2024/05/11	05 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:GTLS	Chart Industries Inc
2024/05/11	05 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PHIN	PHINIA Inc
2024/05/11	05 : 02	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:RLYB	Rallybio Holdings LLC
2024/05/11	05 : 02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SKYE	Skye Bioscience Inc
2024/05/11	05 : 02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TTD	The Trade Desk Inc
2024/05/11	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:SLCA	Silica Holdings Inc
2024/05/11	05 : 02	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:TRNR	Interactive Strength Inc
2024/05/11	05 : 02	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NYSE:SKLZ	Skillz Inc
2024/05/11	05 : 02	Business Wire	Scribe Therapeutics Presents Data Demonstrating Highly Potent Gene Editing In Vivo, Including Saturated Editing of Hepatocytes in NHPs, by an Engineered XE Genome Editor; Showcases Novel Epigenetic Editing Capabilities at 2024 ASGCT Annual Meeting
2024/05/11	05 : 02	GlobeNewswire Inc.	Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam	NASDAQ:SAVA	Cassava Sciences Inc
2024/05/11	05 : 01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:XPNGF	Xpeng Inc (PK)
2024/05/11	05 : 01	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:NCNO	nCino Inc
2024/05/11	05 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:APPDW	Applied DNA Sciences Inc (PK)